Monomers and oligonucleotides comprising cycloaddition adduct(s)
US9566340B2 · kind B2 · utility
9Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2015 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Oct 20, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features compounds of formula V or XII:In one embodiment, the invention relates compounds and processes for conjugating ligand to oligonucleotide. The invention further relates to methods for treating various disorders and diseases such as viral infections, bacterial infections, parasitic infections, cancers, allergies, autoimmune diseases, immunodeficiencies and immunosuppression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.